ロード中...
Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin
Recurrence of Clostridium difficile infection (CDI) occurs in approximately 25% of successfully treated patients. Two phase 3 randomized, double-blind trials were conducted at 154 sites in the United States, Canada, and Europe to compare fidaxomicin vs vancomycin in treating CDI. Patients with CDI r...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3388030/ https://ncbi.nlm.nih.gov/pubmed/22752865 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cis462 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|